Roche Molecular Systems Business Systems Analyst Salaries in Lansing, MI
The average Roche Molecular Systems Business Systems Analyst in Lansing, MI earns an estimated $90,914 annually, which includes an estimated base salary of $81,103 with a $9,811 bonus. Roche Molecular Systems' Business Systems Analyst compensation is $7,443 more than the US average for a Business Systems Analyst. Business Systems Analyst salaries at Roche Molecular Systems in Lansing, MI can range from $36,000 - $350,000.
In Lansing, MI, The Operations Department at Roche Molecular Systems earns $8,563 more on average than the Finance Department.
Last updated a year ago.
- $81,103
- avg. base
- $9,811
- avg. bonus
Business Systems Analyst Salaries at Roche Molecular Systems
In Lansing, MI, Business Systems Analysts earn $3,157 more than Business Analysts, and $24,791 less than Operations Managers.
Compensation at Roche Molecular Systems by Department
In Lansing, MI, The Operations Department averages $8,563 more than the Finance Department, and $6,979 less than the Marketing Department
Business Systems Analyst Compensation by Gender (All Companies)
The average female Business Systems Analyst at companies similar size to Roche Molecular Systems reported making $89,933, while the average male Business Systems Analyst at similar sized companies reported making $93,781.
Business Systems Analyst Compensation by Ethnicity (All Companies)
The average Native American Business Systems Analyst at companies similar size to Roche Molecular Systems reported making $115,000, while the average African American/Black Business Systems Analyst at similar sized companies reported making $75,705.
How Business Systems Analysts at Roche Molecular Systems Rate Their Compensation
The majority of Business Systems Analysts at Roche Molecular Systems believe they're compensated fairly. 100% of Business Systems Analysts at Roche Molecular Systems say they receive annual bonuses, and the majority (60%) are satisfied with their benefits. See more compensation ratings at Roche Molecular Systems
